IP Library Assignment 045351/0787
Patent Assignment
Reel/Frame 045351/0787

Assignment of Assignor's Interest

Recorded: 2018-03-26 Pages: 4
Assignors
BOSS, CHRISTOPH
Executed: 2016-04-27
BROTSCHI, CHRISTINE
Executed: 2016-04-27
GUDE, MARKUS
Executed: 2016-04-27
HEIDMANN, BIBIA
Executed: 2016-04-27
SIFFERLEN, THIERRY
Executed: 2016-04-27
VON RAUMER, MARKUS
Executed: 2016-04-27
WILLIAMS, JODI T.
Executed: 2016-04-27
Assignee
ACTELION PHARMACEUTICALS LTD
GEWERBESTRASSE 16, ALLSCHWIL, CH-4123, SWITZERLAND
Covered Property (1)
Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1-Yl)(5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone as Orexin Receptor Antagonist
Application: 15/702,281 →
Publication: US 2018/0002317
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 25, 2018
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 046244/0794 →
Patent Security Agreement Jun 25, 2026
From: IDORSIA PHARMACEUTICALS LTD
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 076038/0461 →